Skip to main content
. 2020 Aug 4;109(12):1540–1548. doi: 10.1007/s00392-020-01723-9

Table 1.

Admission rates and baseline characteristics and comorbidities of pre-COVID vs. COVID groups (January to May 2019 vs. January to May 2020)

STEMI NSTEMI Acute limb ischemia Aortic rupture Stroke TIA
Pre-COVID COVID Pre-COVID COVID Pre-COVID COVID Pre-COVID COVID Pre-COVID COVID Pre-COVID COVID
No. of patients, n 3,350 2,940 7,682 6,518 2,331 2,041 257 215 15,969 14,546 6,252 5,342
Admission rate per 100,000 7.3 6.6 16.8 14.6 5.1 4.6 0.6 0.5 35.0 32.5 13.7 11.9
Absolute change (%) − 12.2# − 15.2# − 12.4# − 16.3 (n.s.) − 8.9# − 14.6#
February (%) − 0.5 − 9.0 − 9.5 − 3.8  + 0.1 − 7.5
March (%) − 20.8 − 19.6 − 0.2 − 7.3 − 5.4 − 22.6
April (%) − 16.3 − 21.5 − 22.5 − 38.2 − 17.8 − 30.2
Mai (%) − 9.0 − 18.6 − 26.0 − 46.9 − 21.2 − 12.1

Fractiona of interventional/

open-surgical treatment, %

84.7 86.3 58.0 60.5 81.9 82.8 51.5 56.7 18.4 19.1 2.1 2.2
In-hospital mortality, %

11.9

(10.8–13.0)

12.1

(11.0–13.4)

6.0

(5.5–6.6)

5.6

(5.1–6.2)

5.6

(4.7–6.6)

5.4

(4.5–6.5)

44.4

(38.2–50.7)

37.2

(30.7–44.0)

8.5#

(8.1–9.0)

9.8#

(9.3–10.3)

0.3

(0.2–0.5)

0.5

(0.3–0.7)

Female, % 38.2 38.7 40.4 41.8 51.4 53.1 40.9 38.6 55.3 55.5 59.3 59.4
Mean age, years 68 68 74 73 73 73 76 74 75 76 74 74
Diabetes

22.2

(20.8–23.7)

23.3

(21.8–24.9)

31.3

(30.3–32.4)

31.4

(30.3–32.6)

26.2

(24.4–28.1)

27.2

(25.3–29.2)

10.1

(6.7–14.5)

10.7

(6.9–15.6)

25.4

(24.7–26.1)

25.5

(24.8–26.2)

20.3

(19.3–21.3)

20.7

(19.6–21.8)

Obesity

6.5

(5.6–7.3)

7.5

(6.6–8.5)

7.5

(6.9–8.1)

7.4

(6.7–8.0)

5.7

(4.8–6.7)

5.6

(4.6–6.7)

4.3

(2.2–7.5)

3.7

(1.6–7.2)

4.7

(4.4–5.0)

4.0

(3.7–4.3)

3.5

(3.1–4.0)

3.3

(2.8–3.8)

Hypertension

67.6

(65.9–69.1)

68.7

(67.0–70.4)

77.3#

(76.4–78.3)

79.3#

(78.3–80.3)

71.6#

(69.7–73.4)

75.6#

(73.6–77.4)

59.9

(53.7–66.0)

60.0

(53.1–66.6)

76.6#

(75.9–77.2)

77.8#

(77.2–78.5)

72.8

(71.7–73.9)

73.5

(72.3–74.7)

Ischemic heart disease

93.2

(92.3–94.1)

94.1

(93.2–94.9)

87.8

(87.1–88.6)

88.1

(87.3–88.9)

26.4

(24.7–28.3)

27.8

(25.9–29.8)

23.7

(18.7–29.4)

19.1

(14.1–25.0)

14.7

(14.2–15.3)

14.6

(14.0–15.2)

13.4

(12.6–14.3)

13.0

(12.1–13.9)

Atrial fibrillation

17.9

(16.6–19.3)

15.3

(14.0–16.7)

26.4

(25.4–27.4)

26.4

(25.3–27.5)

23.1

(21.4–24.9)

24.6

(22.7–26.5)

29.6

(24.1–35.6)

29.8

(23.7–36.4)

30.6

(29.9–31.4)

30.3

(29.5–31.0)

22.4

(21.4–23.5)

21.6

(20.5–22.7)

Heart failure

39.9

(38.2–41.5)

39.6

(37.8–41.4)

40.5

(39.4–41.6)

40.1

(38.8–41.2)

13.4

(12.1–14.9)

13.6

(12.2–15.2)

17.9

(13.4–23.1)

18.1

(13.2–24.0)

10.9

(10.4–11.4)

11.2

(10.7–11.7)

6.7

(6.1–7.4)

6.8

(6.2–7.5)

COPD

5.2

(4.4–6.0)

4.9

(4.2–5.8)

8.8

(8.2–9.4)

7.8

(7.2–8.5)

10.3

(9.1–11.6)

12.0

(10.6–13.4)

10.1

(6.7–14.5)

7.0

(4.0–11.3)

4.7

(4.4–5.0)

5.0

(4.6–5.3)

4.1

(3.7–4.7)

3.3

(2.9–3.9)

Chronic renal disease

13.5

(12.3–14.7)

12.1

(11.0–13.3)

24.3

(23.4–25.3)

23.5

(22.5–24.5)

23.8

(22.1–25.6)

24.9

(23.0–26.8)

20.6

(15.9–26.1)

16.3

(11.6–21.9)

15.3

(14.7–15.8)

14.7

(14.2–15.3)

11.1

(10.4–11.9)

12.4

(11.6–13.3)

Cancer

1.7

(1.3–2.2)

1.7

(1.3–2.3)

2.6

(2.3–3.0)

2.2

(1.9–2.6)

3.4

(2.7–4.2)

2.8

(2.2–3.7)

3.1

(1.4–6.0)

5.6

(2.9–9.6)

3.4

(3.2–3.7)

3.3

(3.0–3.6)

1.9

(1.6–2.2)

1.8

(1.4–2.2)

Proportions for comorbidities are presented as % with 95% confidence interval in parentheses

#Statistically significant differences (p < 0.05). n.s. not significant

aFraction denotes the percentage of patients admitted for cardiovascular and cerebrovascular emergencies, who underwent respective interventional or open-surgical treatment. STEMI: ST-segment elevation myocardial infarction; NSTEMI: non-STEMI; TIA: transient ischemic attack; COPD: chronic obstructive pulmonary disease